For depletion of CtIP, RAD52 and RAD51, a pool of three siRNAs, specific for each protein, as previously described (Kostyrko et al., 2017) (Eurogentec), was introduced by electroporation (Nucleofector™ II device, Amaxa Biosystems) following manufacturer’s protocol and program U-23. Briefly, the following oligonucleotides were used for depletion of CtIP: 5′-GUGCAAGGUUUACAAAUAA-3′; 5′-CAAAGUCCCUGCCAAACAA-3′; 5′-AGAAUACUCUCCAGGAAGA-3′ (Eurogentec). Similarly, for downregulation of RAD52, again a cocktail of three specific RNAs was utilized, following the same transfection procedure: 5′-UGAGAUGUUUGGUUACAAU-3′; 5′-ACUGCAUUCUGGACAAAGA-3′; 5′-CCCUGAAGACAACCUUGAA-3′. For efficient RAD51 ablation the following three specific siRNA sequences were used: 5′-GUGCCAAUGAUGUGAAGAA-3′; 5′-GGGAAUUAGUGAAGCCAAA-3′; 5′-GGCGUUCAGAAAUCAUACA-3′. The following negative control RNA (ncRNA) sequence was used: 5′-UUCUCCGAACGUGUCACGUdTdT-3′. ncRNA is used for mock-transfection.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.